Literature DB >> 22961073

Vitamin D and cardiovascular disease: is there evidence to support the bandwagon?

Giovanni Annuzzi1, Giuseppe Della Pepa, Claudia Vetrani.   

Abstract

In the last 3 years, more evidence accumulated that vitamin D (vitD)deficiency associates with cardiovascular disease (CVD) and risk factors. The association with higher cardiovascular (CV) mortality was stronger than with nonfatal CVD events. A higher incidence of type 2 diabetes was also shown. Many factors related to lifestyle (physical activity in particular) influence both vitD levels and CVD, and may contribute to explain these observational data. Whether the association between vitD and CVD is causal can only be established through randomized controlled trials (RCTs), and to date the results of the randomized trials, which were not designed for investigating CV outcomes, do not support the association data. Answers on the effects of vitD supplementation on primary and secondary prevention of CV may be found in the specifically designed ongoing RCTs. In the mean time, low vitamin D levels should be regarded as a marker of unhealthy lifestyle, requiring a more aggressive attempt at modifying individual lifestyle.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961073     DOI: 10.1007/s11883-012-0281-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  48 in total

1.  Low dietary vitamin D predicts 34-year incident stroke: the Honolulu Heart Program.

Authors:  Gotaro Kojima; Christina Bell; Robert D Abbott; Lenore Launer; Randi Chen; Heather Motonaga; G Webster Ross; J David Curb; Kamal Masaki
Journal:  Stroke       Date:  2012-05-24       Impact factor: 7.914

2.  Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study.

Authors:  Enju Liu; James B Meigs; Anastassios G Pittas; Christina D Economos; Nicola M McKeown; Sarah L Booth; Paul F Jacques
Journal:  Am J Clin Nutr       Date:  2010-04-14       Impact factor: 7.045

3.  No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year.

Authors:  R Jorde; M Sneve; P Torjesen; Y Figenschau
Journal:  J Intern Med       Date:  2009-10-19       Impact factor: 8.989

Review 4.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

5.  Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial.

Authors:  Pamela R von Hurst; Welma Stonehouse; Jane Coad
Journal:  Br J Nutr       Date:  2009-09-28       Impact factor: 3.718

6.  Vitamin D status and the risk of cardiovascular disease death.

Authors:  Annamari Kilkkinen; Paul Knekt; Antti Aro; Harri Rissanen; Jukka Marniemi; Markku Heliövaara; Olli Impivaara; Antti Reunanen
Journal:  Am J Epidemiol       Date:  2009-09-17       Impact factor: 4.897

7.  Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial.

Authors:  Andrea Z LaCroix; Jane Kotchen; Garnet Anderson; Robert Brzyski; Jane A Cauley; Steven R Cummings; Margery Gass; Karen C Johnson; Marcia Ko; Joseph Larson; JoAnn E Manson; Marcia L Stefanick; Jean Wactawski-Wende
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-16       Impact factor: 6.053

8.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

Authors:  Armin Zittermann; Sabine Frisch; Heiner K Berthold; Christian Götting; Joachim Kuhn; Knut Kleesiek; Peter Stehle; Heinrich Koertke; Reiner Koerfer
Journal:  Am J Clin Nutr       Date:  2009-03-25       Impact factor: 7.045

9.  Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.

Authors:  Tae Nyun Kim; Man Sik Park; Kang Il Lim; Hae Yoon Choi; Sae Jeong Yang; Hye Jin Yoo; Hyun Joo Kang; Wook Song; Hyuk Choi; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

10.  Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study.

Authors:  Barbara Thorand; Astrid Zierer; Cornelia Huth; Jakob Linseisen; Christa Meisinger; Michael Roden; Annette Peters; Wolfgang Koenig; Christian Herder
Journal:  Diabetes Care       Date:  2011-08-26       Impact factor: 19.112

View more
  4 in total

Review 1.  Role of vitamin D in the development of insulin resistance and type 2 diabetes.

Authors:  Stefan Pilz; Katharina Kienreich; Femke Rutters; Renate de Jongh; Adriana J van Ballegooijen; Martin Grübler; Andreas Tomaschitz; Jacqueline M Dekker
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

2.  Is the Association between Vitamin D and Cardiovascular Disease Risk Confounded by Obesity? Evidence from the Andhra Pradesh Children and Parents Study (APCAPS).

Authors:  Christopher Paul Baker; Bharati Kulkarni; K V Radhakrishna; M S Charyulu; John Gregson; Mika Matsuzaki; Amy E Taylor; Dorairaj Prabhakaran; Raja Sriswan Mamidi; Jonathan Wells; Ian Wilkinson; Carmel McEniery; George Davey Smith; Yoav Ben-Shlomo; Hannah Kuper; Sanjay Kinra
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

3.  Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC).

Authors:  Hugh Tunstall-Pedoe; Mark Woodward; Maria Hughes; Annie Anderson; Gwen Kennedy; Jill Belch; Kari Kuulasmaa
Journal:  Int J Epidemiol       Date:  2015-06-21       Impact factor: 7.196

Review 4.  Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.

Authors:  Giuseppe Della Pepa; Claudia Vetrani; Gianluca Lombardi; Lutgarda Bozzetto; Giovanni Annuzzi; Angela Albarosa Rivellese
Journal:  Nutrients       Date:  2017-09-26       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.